.
SUNPHARMA financial statements
* Numbers in billions
| Capitalization * | 2 164 |
|---|---|
| EV * | 1 546 |
| Number of shares * | 2 |
| EPS | 12,10 |
| Revenue * | 335 |
| Net income * | 29 |
| Operating profit * | 64 |
| Total liabilities * | 182 |
| Net debt * | -24 |
| Total assets * | 677 |
| Equity * | 465 |
| Cash and investments * | 96 |
.
SUNPHARMA valuation
| P/E | 74,53 |
|---|---|
| P/B | 4,66 |
| P/S | 6,46 |
| E/P | 1 |
| P/FCF | 43,28 |
.
SUNPHARMA profitability
| ROE | 6% |
|---|---|
| ROA% | 5% |
| ROIC% | 12% |